Methadone versus morphine for treatment of neonatal abstinence syndrome: A prospective randomized clinical trial

Journal of Perinatology

Volumn 35, Issue 4, 2015, Pages 278-283

  Brown, M S ^a   Hayes, M J ^b   Thornton, L M ^a  

^a EASTERN MAINE MEDICAL CENTER   (United States)

^b University of Maine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CLONAZEPAM; METHADONE; PHENOBARBITAL; MORPHINE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EXPOSURE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME; BIRTH WEIGHT; COMPARATIVE STUDY; LENGTH OF STAY; NEONATAL ABSTINENCE SYNDROME; NEWBORN;

ANALGESICS, OPIOID; BIRTH WEIGHT; BUPRENORPHINE; DOUBLE-BLIND METHOD; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; METHADONE; MORPHINE; NEONATAL ABSTINENCE SYNDROME; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84925947178     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.194     Document Type: Article

References (36)

1. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307: 1934-1940
2. Hayes MJ, Brown MS. Epidemic of prescription opiate abuse and neonatal abstinence. JAMA 2012; 307: 1974-1975
3. Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol 2014; 123: 997-1002
4. Hudak ML, Tan RC. The Committee on Drugs and the Committee on Fetus and Newborn Neonatal drug withdrawal. Pediatrics 2012; 129: e540-e560
5. Lipsitz PJ. A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr (Phila) 1975; 14: 592-594
6. Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs. Pediatrics 1998; 101: 1079-1088
7. Finnegan L, Kaltenbach K. Neonatal abstinence syndrome:assessment and pharmacotherapy In: Hoekelman R, Friedman SB, Nelson NM (ed) Primary Care Pediatrics2 edn.Mosby: St. Louis, 1992 pp 1367-1378
8. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 2006; 26: 15-17
9. O'Grady MJ, Hopewell J, White MJ. Management of neonatal abstinence syndrome: a national survey and review of practice. Arch Dis Child Fetal Neonatal Ed 2009; 94: F249-F252
10. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007; 87: 131-138
11. Langenfeld S, Birkenfeld L, Herkenrath P, Muller C, Hellmich M, Theisohn M. Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops. Drug Alcohol Depend 2005; 77: 31-36
12. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care 2005; 5: 265-272
13. Kraft WK, Gibson E, Dysart K, Damle VS, Larusso JL, Greenspan JS et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics 2008; 122: e601-e607
14. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991; 118: 933-937
15. Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE et al. Buprenorphine versus methadone in the treatment of pregnant opioiddependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005; 79: 1-10
16. Lintzeris N, Nielsen S. Benzodiazepines, methadone and buprenorphine: interactions and clinical management. Am J Addict 2010; 19: 59-72
17. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331
18. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006; 117: e1163-e1169
19. Ballard JL. Treatment of neonatal abstinence syndrome with breast milk containing methadone. J Perinat Neonatal Nurs 2002; 15: 76-85
20. Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarko L, Ravndal E. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatr 2013; 102: 1060-1066
21. Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA. Roomingin compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician 2007; 53: 1722-1730
22. Wachman EM, Hayes MJ, Brown MS, Paul J, Harvey-Wilkes K, Terrin N et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA 2013; 309: 1821-1827
23. Wachman EM, Hayes MJ, Lester BM, Terrin N, Brown MS, Nielsen DA et al. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr 2014; 165: 472-478
24. Surran B, Visintainer P, Chamberlain S, Kopcza K, Shah B, Singh R. Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial. J Perinatol 2013; 33: 954-959
25. Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 2005; 19: 13-24
26. Ward RM, Drover DR, Hammer GB, Stemland CJ, Kern S, Tristani-Firouzi M et al. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children. Paediatr Anaesth 2014; 24: 591-601
27. Farid WO, Dunlop SA, Tait RJ, Hulse GK. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol 2008; 6: 125-150
28. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: Part 2-Clinical use. Paediatr Anaesth 1997; 7: 93-101
29. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: Part 1-Pharmacokinetics. Paediatr Anaesth 1997; 7: 5-11
30. Walker PW, Palla S, Pei BL, Kaur G, Zhang K, Hanohano J et al. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?. J Palliat Med 2008; 11: 1103-1108
31. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician 2008; 11(2 Suppl) S133-S153
32. Cox BM. Recent developments in the study of opioid receptors. Mol Pharmacol 2013; 83: 723-728
33. Kristensen K, Christensen CB, Christrup LL. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 1995; 56: PL45-PL50
34. Saidak Z, Blake-Palmer K, Hay DL, Northup JK, Glass M. Differential activation of G-proteins by mu-opioid receptor agonists. Br J Pharmacol 2006; 147: 671-680
35. Parsons CG. NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol 2001; 429: 71-78
36. Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M et al. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010; 105: 2071-2084